---
figid: PMC3920940__cddis2013407f7
figlink: /pmc/articles/PMC3920940/figure/fig7/
number: Figure 7
caption: Diagram showing the model proposed for the association of EMT, CSCs and the
  PI3K/Akt/mTOR signaling pathway in CaP radioresistance and the effect of possible
  action of BEZ235 on radiosensitivity. (a) RT can induce CaP-RR cells with EMT and
  enhanced CSC phenotypes, and activation of the PI3K/Akt/mTOR signaling pathway,
  resulting in CaP metastasis and recurrence after RT. (b) A dual PI3K/mTOR inhibitor
  BEZ235 combined with RT can inactivate the PI3K/Akt/mTOR signaling pathway, reducing
  EMT and CSC phenotypes and leading to increased radiosensitivity. All data used
  in RR cell lines were based on cells between 5 and 6 weeks post radiation treatment
pmcid: PMC3920940
papertitle: Acquisition of epithelial–mesenchymal transition and cancer stem cell
  phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate
  cancer radioresistance.
reftext: L Chang, et al. Cell Death Dis. 2013 Oct;4(10):e875.
pmc_ranked_result_index: '7837'
pathway_score: 0.9587559
filename: cddis2013407f7.jpg
figtitle: Diagram showing the model proposed for the association of EMT, CSCs and
  the PI3K/Akt/mTOR signaling pathway in CaP radioresistance and the effect of possible
  action of BEZ235 on radiosensitivity
year: '2013'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3920940__cddis2013407f7.html
  '@type': Dataset
  description: Diagram showing the model proposed for the association of EMT, CSCs
    and the PI3K/Akt/mTOR signaling pathway in CaP radioresistance and the effect
    of possible action of BEZ235 on radiosensitivity. (a) RT can induce CaP-RR cells
    with EMT and enhanced CSC phenotypes, and activation of the PI3K/Akt/mTOR signaling
    pathway, resulting in CaP metastasis and recurrence after RT. (b) A dual PI3K/mTOR
    inhibitor BEZ235 combined with RT can inactivate the PI3K/Akt/mTOR signaling pathway,
    reducing EMT and CSC phenotypes and leading to increased radiosensitivity. All
    data used in RR cell lines were based on cells between 5 and 6 weeks post radiation
    treatment
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT1
  - POU5F1
  - PIK3R6
  - EIF4EBP1
  - ALDH3B1
  - ALDH3A1
  - AKT2
  - CDH2
  - RPS6KB1
  - ALDH1A3
  - ALDH3A2
  - SOX2
  - PIK3R3
  - ALDH2
  - CD44
  - ALDH7A1
  - ALDH1A2
  - SNAI1
  - PIK3R5
  - MTOR
  - NANOG
  - ALDH5A1
  - EPCAM
  - PIK3R4
  - AKT3
  - MET
  - PIK3CG
  - PIK3CA
  - SMN1
  - ALDH1A1
  - CDH1
  - PIK3CB
  - ALDH9A1
  - PIK3CD
genes:
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: OCT3/4
  symbol: Oct4
  source: hgnc_alias_symbol
  hgnc_symbol: POU5F1
  entrez: '5460'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: P-4EBP1
  symbol: 4E-BP1
  source: hgnc_alias_symbol
  hgnc_symbol: EIF4EBP1
  entrez: '1978'
- word: ALDH
  symbol: ALDH
  source: bioentities_symbol
  hgnc_symbol: ALDH3B1
  entrez: '221'
- word: ALDH
  symbol: ALDH
  source: bioentities_symbol
  hgnc_symbol: ALDH3A1
  entrez: '218'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: N-cadherin
  symbol: CDH2
  source: hgnc_symbol
  hgnc_symbol: CDH2
  entrez: '1000'
- word: P-S6K
  symbol: PS6K
  source: hgnc_alias_symbol
  hgnc_symbol: RPS6KB1
  entrez: '6198'
- word: ALDH
  symbol: ALDH
  source: bioentities_symbol
  hgnc_symbol: ALDH1A3
  entrez: '220'
- word: ALDH
  symbol: ALDH
  source: bioentities_symbol
  hgnc_symbol: ALDH3A2
  entrez: '224'
- word: sox2
  symbol: SOX2
  source: hgnc_symbol
  hgnc_symbol: SOX2
  entrez: '6657'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: ALDH
  symbol: ALDH
  source: bioentities_symbol
  hgnc_symbol: ALDH2
  entrez: '217'
- word: CD44
  symbol: CD44
  source: hgnc_symbol
  hgnc_symbol: CD44
  entrez: '960'
- word: ALDH
  symbol: ALDH
  source: bioentities_symbol
  hgnc_symbol: ALDH7A1
  entrez: '501'
- word: ALDH
  symbol: ALDH
  source: bioentities_symbol
  hgnc_symbol: ALDH1A2
  entrez: '8854'
- word: Snail
  symbol: SNAIL
  source: hgnc_alias_symbol
  hgnc_symbol: SNAI1
  entrez: '6615'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: Nanog
  symbol: NANOG
  source: hgnc_symbol
  hgnc_symbol: NANOG
  entrez: '79923'
- word: ALDH
  symbol: ALDH
  source: bioentities_symbol
  hgnc_symbol: ALDH5A1
  entrez: '7915'
- word: CD326
  symbol: CD326
  source: hgnc_alias_symbol
  hgnc_symbol: EPCAM
  entrez: '4072'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: MET
  symbol: MET
  source: hgnc_symbol
  hgnc_symbol: MET
  entrez: '4233'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: «SMA
  symbol: SMA
  source: hgnc_prev_symbol
  hgnc_symbol: SMN1
  entrez: '6606'
- word: ALDH
  symbol: ALDH
  source: bioentities_symbol
  hgnc_symbol: ALDH1A1
  entrez: '216'
- word: E-cadherin
  symbol: CDH1
  source: hgnc_symbol
  hgnc_symbol: CDH1
  entrez: '999'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: ALDH
  symbol: ALDH
  source: bioentities_symbol
  hgnc_symbol: ALDH9A1
  entrez: '223'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
chemicals: []
diseases: []
---
